Cat. No. | Product name | CAS No. |
DC50091 |
Phthalazinone pyrazole
Featured
Phthalazinone pyrazole is a potent inhibitor of Aurora A kinase (IC50 = 31 nM). |
880487-62-7 |
DC50092 |
Arginase inhibitor 1
Featured
Arginase inhibitor 1 is a potent inhibitor of human arginases I and II with IC50s of 223 and 509 nM, respectively. |
1345808-25-4 |
DC50093 |
USL-311
Featured
USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells. |
1373268-67-7 |
DC50096 |
GW604714X
Featured
GW604714X is a novel potent and selective inhibitor of mitochondrial respiration supported by pyruvate. |
853953-65-8 |
DC50098 |
TRPV4 agonist-1
Featured
TRPV4 agonist-1 free base is a transient receptor potential vanilloid 4 (TRPV4) agonist with an EC50 of 60 nM in the hTRPV4 Ca2+ assay. |
2314467-59-7 |
DC70007 |
Benzyl-piperazine-CO-benzothiazole-4-methylpiperidine
Featured
Benzyl-piperazine-CO-benzothiazole-4-methylpiperidine alters the lifespan of a eukaryotic organism. |
906258-48-8 |
DC70008 |
CLinDMA
Featured
CLinDMA, a cationic lipid, can cause inflammatory response. CLinDMA can be used for the synthesis LNP201. LNP201 is a liposome assembly for systemic delivery of siRNA. |
908860-82-2 |
DC70010 |
98N12-5
Featured
98N12-5 is an ionizable cationic lipid. It has been used in combination with other lipids in the generation of lipid nanoparticles (LNPs). LNPs containing 98N12-5 and encapsulating proprotein convertase subtilisin kexin type 9 (PCSK9) siRNA selectively accumulate in the liver and reduce total serum cholesterol levels in mice and rats and serum LDL levels in cynomolgus monkeys. |
917572-74-8 |
DC70046 |
MRTX 0902
Featured
MRTX0902 is a potent SOS1 inhibitor with an IC50 of 46 nM (WO2021127429A1; Example 12-10). |
2654743-22-1 |
DC70063 |
CFI-402257(luvixasertib)
Featured
CFI-402257(luvixasertib) is a potent and selective Mps1/TTK kinase inhibitor with Ki of 0.1 nM and cellular Mps1 EC50 of 6.5 nM. |
1610759-22-2 |
DC70085 |
Nedisertib (Synonyms: Peposertib; M3814)
Featured
Nedisertib (M3814, MSC2490484A) is a highly potent, selective, orally bioavailable inhibitor of DNA-PK. |
1637542-33-6 |
DC70086 |
GSK-484
Featured
GSK-484 is a potent, highly selective and reversible protein arginine deiminase PAD4 inhibitor with IC50 of 80 nM in FP binding assay (0.2 mM Ca), 50 nM in PAD4 NH3 release inhibition assay. |
1652629-23-6 |
DC70087 |
Desmopressin
Featured
Desmopressin is a synthetic analogue of the antidiuretic hormone arginine vasopressin. |
16679-58-6 |
DC70091 |
GSK3186899
Featured
GSK 3186899 (GSK-3186899, DDD853651) is a novel specific inhibitor of parasite cdc-2-related kinase 12 (CRK12), shows activity against L. donovani in intra-macrophage assay with EC50 value of 1.4 uM, and shows good selectivity against mammalian THP-1 host cells (EC50> 50 uM). |
1972617-87-0 |
DC70095 |
NSD1 inhibitor BT5
Featured
NSD1 inhibitor BT5 is a covalent, small molecule inhibitor of NSD1 histone methyltransferase with IC50 of 1.4 uM, shows no covalent binding to NSD2. |
2351225-46-0 |
DC70098 |
KT-531
Featured
KT-531 (KT531) is a potent, selective HDAC6 inhibitor with IC50 of 8.5 nM, displays 39-fold selectivity. |
2490284-18-7 |
DC70101 |
INE963
Featured
INE963 (INE-963) is a potent and fast-acting blood-stage antimalarial, demonstrates potent cellular activity against Pf 3D7 with EC50 of 6 nM in Pf growth inhibition assay. |
2640567-43-5 |
DC70102 |
ITK inhibitor
Featured
ITK inhibitor (CAS 439574-61-5 ) is a Interleukin-2-inducible T-cell kinase (Itk) inhibitor.. |
439574-61-5 |
DC70103 |
MS.001
Featured
MS.001 is a small molecule that inhibits both the chaperone binding and ubiquitin ligase activity of C-terminus of Hsc70 interacting protein (CHIP) at low micromolar concentrations (IC50=3.3 uM). |
53619-67-3 |
DC70104 |
Elacestrant
Featured
Elacestrant (RAD-1901) is a novel, orally bioavailable small-molecule selective estrogen receptor degrader (SERD). |
722533-56-4 |
DC70109 |
(R)-CR8
Featured
(R)-CR8 is a potent CDK1/2/5/7/9 inhibitor, inhibits CDK1/cyclin B (IC50, 90 nM), CDK2/cyclin A (72 nM), CDK2/cyclin E (41 nM), CDK5/p25 ( 110 nM), CDK7/cyclin H (1.1 uM), CDK9/cyclin T (0.18 uM) and CK1δ/ε (0.4 uM); (R)-CR8 induces apoptosis and has neuroprotective effect, CR8 alsp acts as a molecular glue degrader that depletes cyclin K. |
294646-77-8 |
DC70134 |
Oxytocin
Featured
A peptide hormone and neuropeptide that is released into the bloodstream as a hormone in response to stretching of the cervix and uterus during labor and with stimulation of the nipples from breastfeeding. |
50-56-6 |